Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Lacetera

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Urology|March 17, 2024
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al.
European Urology Focus|October 9, 2022
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, et al.
The Prostate|January 27, 2023
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
World Journal of Urology|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
European Urology Oncology|October 24, 2022
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM ClassificationMichael Baboudjian, Bastien Gondran-Tellier, Alae Touzani, et al.
European Urology Focus|September 24, 2022
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical ProstatectomyRomain Diamand, Jean-Baptiste Roche, Elena Lievore, et al.
European Urology Focus|May 5, 2023
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter StudyGeorges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2018
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patientsMarco Oderda, Giancarlo Marra, Simone Albisinni, et al.
World Journal of Urology|March 15, 2023
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approachMichael Baboudjian, Alberto Breda, Thierry Roumeguère, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Urology|March 17, 2024
Does Overgrading on Targeted Biopsy of Magnetic Resonance Imaging-visible Lesions in Prostate Cancer Lead to Overtreatment?Michael Baboudjian, Romain Diamand, Alessandro Uleri, et al.
European Urology Focus|October 9, 2022
Expanding Active Surveillance Criteria for Low- and Intermediate-risk Prostate Cancer: Can We Accurately Predict the Risk of Misclassification for Patients Diagnosed by Multiparametric Magnetic Resonance Imaging-targeted Biopsy?Romain Diamand, Simone Albisinni, Jean-Baptiste Roche, et al.
The Prostate|January 27, 2023
Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining-targeted biopsyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
World Journal of Urology|December 12, 2022
Optimizing multiparametric magnetic resonance imaging-targeted biopsy and prostate cancer grading accuracyRomain Diamand, Alexandre Peltier, Jean-Baptiste Roche, et al.
European Urology Oncology|October 24, 2022
Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM ClassificationMichael Baboudjian, Bastien Gondran-Tellier, Alae Touzani, et al.
European Urology Focus|September 24, 2022
External Validation of Models for Prediction of Side-specific Extracapsular Extension in Prostate Cancer Patients Undergoing Radical ProstatectomyRomain Diamand, Jean-Baptiste Roche, Elena Lievore, et al.
European Urology Focus|May 5, 2023
A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter StudyGeorges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 7, 2018
Accuracy of elastic fusion biopsy in daily practice: Results of a multicenter study of 2115 patientsMarco Oderda, Giancarlo Marra, Simone Albisinni, et al.
World Journal of Urology|March 15, 2023
Expanding inclusion criteria for active surveillance in intermediate-risk prostate cancer: a machine learning approachMichael Baboudjian, Alberto Breda, Thierry Roumeguère, et al.
Pageof 4